Flexible Solutions International Inc: Form 10-Q for the period ended Sep 30, 2024
Filed with the SEC on Nov 14, 2024 and accepted by EDGAR at Nov 14, 2024, 21:00 ET.
Management's discussion and analysis
As filed, 8,539 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview
The Company manufactures and markets biodegradable polymers which are used in the oil, gas and agriculture industries. The Company also develops, manufactures and markets specialty chemicals that slow the evaporation of water.
Results of Operations
We have three product lines.
The first is a chemical (“EWCP”) used in swimming pools and spas. The product forms a thin, transparent layer on the water’s surface. The transparent layer slows the evaporation of water, allowing the water to retain a higher temperature for a longer period of time thereby reducing the energy required to maintain the desired temperature of the water. A modified version of EWCP can also be used in reservoirs, potable water storage tanks, livestock watering pods, canals, and irrigation ditches for the purpose of reducing evaporation.
The second product, biodegradable polymers (“TPAs”), is used by the petroleum, chemical, utility and mining industries to prevent corrosion and scaling in water piping. TPAs can also be used to increase biodegradability in detergents and in the agriculture industry to increase crop yields by enhancing fertilizer uptake.
The third product line is nitrogen conservation products used for the agriculture industry. These products decrease the loss of nitrogen fertilizer after initial application and allows less fertilizer to be used. These products are made and sold by the Company’s TPA division.
Material changes in the Company’s Statement of Operations for nine and three months ended September 30, 2024 compared to the same period in the prior year are discussed below:
Nine Months ended September 30, 2024
| Item | Increase (I) or Decrease (D) | Reason |
| Sales | ||
| EWCP products | I | Increased customer orders. |
| TPA products | I | Increased customer orders. |
| Gross profit | I | Raw material costs declined to catch up with customer price reductions already in place. |
| Wages | D | Increased reliance on consultants instead of full time employees. |
| Administrative salaries and benefits | D | One time decrease in the salary of Dan O’Brien effective October 2023. |
| Insurance | I | Prior year increase in assets and in sales resulted in higher insurance costs. |
| Office and Miscellaneous | I | One time moving costs associated with closing the Naperville location. |
| Interest expense | I | Increased debt resulted in increased interest expense. |
| Consulting | I | Increased reliance on consultants instead of full time employees. |
| Research | I | New product development. |
| Utilities | I | Addition of real estate not yet rented out. |
| Investor relations | D | Reduced shares traded and filings required in 2023 did not reoccur in 2024. |
| Currency exchange | I | Currency exchange increased as a result of movements in the US / Canadian dollar exchange rate and its effects on US dollar cash balances and US dollar payables held by the Company’s Canadian subsidiaries. |
| Lease expense | D | Termination of lease in Naperville, IL reduced costs. |
| Loss on lease termination | I | One time cost incurred terminating lease in Naperville, IL. |
| Interest income | I | Increased interest rates combined with increase in term deposits. |
| Gain on investment | D | Sale of 30.1% of Florida based LLC reduced our Company’s portion of the profits. |
| Loss on sale of investment | I | One time loss on the sale of 30.1 % of Florida based LLC, |
24
Three Months ended September 30, 2024
| Item | Increase (I) or Decrease (D) | Reason |
| Sales | ||
| EWCP products | I | Increased customer orders. |
| TPA products | I | Increased customer orders. |
| Gross profit | I | Raw material costs declined to catch up with customer price reductions already in place. |
| Administrative salaries and benefits | D | One time decrease in the salary of Dan O’Brien effective October 2023. |
| Insurance | I | Prior year increase in assets and in sales resulted in higher insurance costs. |
| Office and Miscellaneous | I | One time moving costs associated with closing the Naperville location. |
| Interest expense | I | Increased debt resulted in increased interest expense. |
| Consulting | I | Increased reliance on consultants instead of full time employees. |
| Utilities | I | Addition of real estate not yet rented out. |
| Currency exchange | I | Currency exchange increased as a result of movements in the US / Canadian dollar exchange rate and its effects on US dollar cash balances and US dollar payables held by the Company’s Canadian subsidiaries. |
| Lease expense | D | Termination of lease in Naperville, IL reduced costs. |
| Interest income | I | Increased interest rates combined with increase in term deposits. |
| Gain on investment | D | Sale of 30.1% of Florida based LLC reduced our Company’s portion of the profits. |
| Loss on sale of investment | I | One time loss on the sale of 30.1 % of Florida based LLC, |
Three customers accounted for 60% of our sales during the three months ended September 30, 2024 (2023 –67%) and 52% of our sales during the nine months ended September 30, 2024 (2023 – 49%). The amount of revenue (all from the sale of TPA products) attributable to each customer is shown below.
| Customer | Three months ended September 30, 2024 | 2023 | Nine months ended September 30, 2024 | 2023 | ||||
|---|---|---|---|---|---|---|---|---|
| Company A | $2,812,736 | $2,524,802 | $5,238,881 | $4,728,562 | ||||
| Company B | $1,794,262 | $2,561,698 | $6,606,882 | $7,116,232 | ||||
| Company C | $942,752 | $343,776 | * | $3,399,619 | $2,035,666 | * | ||
| Company D | $754,646 | * | $725,347 | $3,328,826 | * | $2,176,042 |
*not a primary customer in that period
Customers with balances greater than 10% of our receivables as of September 30, 2024 and 2023 are shown below:
| September 30, 2024 | 2023 | |
|---|---|---|
| Company A | $2,571,320 | $2,154,033 |
| Company B | $1,434,983 | $2,274,958 |
Other factors that will most significantly affect future operating results will be:
- the sale price of crude oil which is used in the manufacture of aspartic acid we import from China. Aspartic acid is a key ingredient in our TPA products;
- activity in the oil and gas industry, as we sell our TPA products to oil and gas companies;
- drought conditions, since we also sell our TPA products to farmers; and
Other than the foregoing we do not know of any trends, events or uncertainties that have had, or are reasonably expected to have, a material impact on our revenues or expenses.
Capital Resources and Liquidity
The Company’s sources and (uses) of cash for the nine months ended September 30, 2024 and 2023 are shown below:
| 2024 | 2023 | |
|---|---|---|
| Cash provided (used) by operations | 9,274,106 | 10,128,066 |
| Long term deposits | (1,435,327) | (387,614) |
| Proceeds of equity investment | 430,402 | 101,034 |
| Proceeds from sale of investment | 2,000,000 | - |
| Non-controlling interest of 317 Mendota | - | 200,000 |
| Purchase of investment | - | (470,000) |
| Purchase of equipment | (2,876,119) | (4,326,208) |
| Repayments of short term line of credit | (1,810,479) | (2,818,591) |
| Repayment of long term debt | (917,692) | (542,148) |
| Proceeds of long term debt | 2,162,412 | 2,248,292 |
| Dividends paid | (1,255,053) | (626,777) |
| Lease payments | (50,790) | (43,560) |
| Distributions to non-controlling interest | (365,644) | (537,314) |
| Proceeds from issuance of common stock | 26,250 | 13,600 |
| Changes in exchange rates | 100,276 | 200,334 |
The Company has sufficient cash resources to meets its future commitments and cash flow requirements for the coming year. As of September 30, 2024, working capital was $22,118,657 (December 31, 2023 - $20,172,833) and the Company has no substantial commitments that require significant outlays of cash over the coming fiscal year.
Other than as disclosed above, the Company does not anticipate any capital requirements for the twelve months ending September 30, 2025.
Other than as disclosed above, the Company does not know of any trends, demands, commitments, events or uncertainties that will result in, or that are reasonable likely to result in, its liquidity increasing or decreasing in any material way.
See Note 2 to the condensed interim consolidated financial statements included as part of this report for a description of the Company’s significant accounting policies.
Controls and procedures
As filed, 1,709 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Under the direction and with the participation of our management, including our Principal Executive and Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2024. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports with the Securities and Exchange Commission is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and regulations, and that such information is accumulated and communicated to our management, including our principal executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls and procedures are designed to provide a reasonable level of assurance of reaching desired disclosure control objectives. Based on the evaluation, our Principal Executive and Financial Officer concluded that these disclosure controls and procedures are effective as of September 30, 2024
Changes in Internal Control over Financial Reporting
Our management, with the participation of our Principal Executive and Financial Officer, evaluated whether any change in our internal control over financial reporting occurred during the three months ended September 30, 2024. Based on that evaluation, it was concluded that there has been no change in our internal control over financial reporting during the three months ended September 30, 2024 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-07-01 to 2024-09-30 | $9.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-01-01 to 2024-09-30 | $29.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-07-01 to 2024-09-30 | $5.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-01-01 to 2024-09-30 | $18.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-07-01 to 2024-09-30 | $3.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-01-01 to 2024-09-30 | $10.6m | us-gaap:GrossProfit |
| Research and development | 3 months2024-07-01 to 2024-09-30 | $27.8k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-01-01 to 2024-09-30 | $216.9k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-07-01 to 2024-09-30 | $1.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-01-01 to 2024-09-30 | $4.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-07-01 to 2024-09-30 | $367.6k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-01-01 to 2024-09-30 | $1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-07-01 to 2024-09-30 | $611.9k | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-01-01 to 2024-09-30 | $2.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-07-01 to 2024-09-30 | $0.05 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-01-01 to 2024-09-30 | $0.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-07-01 to 2024-09-30 | $0.05 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-01-01 to 2024-09-30 | $0.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-07-01 to 2024-09-30 | 12,701,812 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-01-01 to 2024-09-30 | 12,536,935 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-01-01 to 2024-09-30 | $9.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-01-01 to 2024-09-30 | $2.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2024-01-01 to 2024-09-30 | $1.3m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2024-09-30 | $10.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-09-30 | $32.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-09-30 | $57.8m | us-gaap:Assets |
| Current liabilities | At period end2024-09-30 | $10.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-09-30 | $17.5m | us-gaap:Liabilities |
| Long-term debt | At period end2024-09-30 | $7.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-09-30 | $2.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-09-30 | $36.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-24-045777. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.